RecruitingNot ApplicableNCT04635020

Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group

A Prospective Randomised Trial Comparing Selective Laser Trabeculoplasty (SLT) and iStent Trabecular Micro-bypass Stent Implantation Combined With Cataract Surgery in Exfoliation Glaucoma


Sponsor

Helsinki University Central Hospital

Enrollment

285 participants

Start Date

Oct 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to investigate the efficacy of an iStent trabecular microbypass stent compared to selective laser trabeculoplasty in combination with cataract surgery in eyes with exfoliation glaucoma (EXF)


Eligibility

Min Age: 50 YearsMax Age: 100 Years

Inclusion Criteria7

  • Signed consent of information
  • Clinical significant cataract
  • Able to attend 12 month period
  • Mild to moderate exfoliation glaucoma according to European glaucoma society guidelines (EGS)
  • Group I stable glaucoma (IOP within individual target IOP), and group II unstable glaucoma (IOP above individual target IOP) with baseline glaucoma medication
  • Target IOP ≥16
  • Able to understand Finnish, Swedish or English

Exclusion Criteria12

  • Clinical set target IOP < 16 mmHg in advanced glaucoma
  • Baseline IOP prior to enrolment ≥30 mmHg, and ≥3 glaucoma medications
  • Closed angle
  • Congenital angle anomaly
  • Clinically significant corneal dystrophy or other hindering corneal condition
  • Unable to use topical medical therapy
  • Central corneal thickness of less than 480um or more than 620um
  • Active uveitis, cystic macular edema (CME), exudative age-related macular degeneration, proliferative diabetic retinopathy or clinical significant macular edema, intraocular neoplasm, intraocular injections, intraocular lens luxation, phacodonesis.
  • Previous intraocular surgery, refractive surgery or cycloablation
  • Two or more prior SLT or laser trabeculoplasty
  • Unable to participate due to another medical disease or condition
  • Participating in another clinical trial

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREiStent

2 trabecular Stent injected at the end of the cataract surgery to the trabecular meshwork

PROCEDURESLT-laser

1 month after cataract surgery laser treatment to the trabecular meshwork (100 applications, 360 degrees)

PROCEDURECataract surgery

Conventional cataract surgery


Locations(1)

Helsinki University Hospital

Helsinki, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04635020


Related Trials